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OBJECTIVE: To predict the American Joint Cancer Committee tumor-node-metastasis stage in patients with
papillary thyroid carcinoma by evaluating the relationship between the preoperative neutrophil-to-lymphocyte
ratio and the tumor-node-metastasis stage.
METHODS: We retrospectively examined 161 patients with a diagnosis of papillary thyroid carcinoma. The
Neutrophil-to-Lymphocyte Ratio was calculated according to the absolute neutrophil counts and absolute
lymphocyte counts on routine blood tests obtained prior to surgery and patients with a Neutrophil-
to-Lymphocyte Ratio of 2.0 or more were classified as the high NLR group, while those with a Neutrophil-
to-Lymphocyte Ratio less than 2.0 were classified as the low Neutrophil-to-Lymphocyte Ratio group.
Clinicopathological variables, which were stratified by the Neutrophil-to-Lymphocyte Ratio, were analyzed.
A multivariate analysis was performed to determine factors that affect the Neutrophil-to-Lymphocyte Ratio. The
association between the Neutrophil-to-Lymphocyte Ratio and the TNM stage in patients X45 years of age was
analyzed using the Spearman rank correlation.
RESULTS: Various blood indices, including hemoglobin, platelet and thyroid-stimulating hormone levels in the
two groups showed no significant differences. Lymph node metastasis, multifocality and tumor size exhibited
significant differences in the two groups (p=0.000, p=0.000 and p=0.035, respectively). Correlation analysis
indicated that a higher preoperative Neutrophil-to-Lymphocyte Ratio was observed in patients with lymph
node metastasis, larger tumor size and multifocality (r=0.341, p=0.000; r=0.271, p=0.000; and r=0.182, p=0.010,
respectively). For patients X45 years of age, the number of patients with an advanced TNM stage in the high
NLR group was higher than that in the low Neutrophil-to-Lymphocyte Ratio group (p=0.013). A linear
regression analysis showed that the preoperative Neutrophil-to-Lymphocyte Ratio was positively correlated
with the American Joint Cancer Committee tumor-node-metastasis stage (rho=0.403, p=0.000).
CONCLUSION: The preoperative Neutrophil-to-Lymphocyte Ratio was closely related to the stage of papillary
thyroid carcinoma. The increase in the preoperative Neutrophil-to-Lymphocyte Ratio contributed to the
advanced tumor-node-metastasis stage of papillary thyroid carcinoma patients X45 years of age.
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’ INTRODUCTION
In recent years, many studies have found that the neutrophil-
to-lymphocyte ratio (NLR) is related to the pathological
characteristics of many tumors. The preoperative NLR is
calculated according to the absolute neutrophil count (ANC)
and the absolute lymphocyte count (ALC) of routine blood tests
obtained prior to surgery. The systemic inflammatory response
has been shown to promote tumor progression and metastases
(1,2). It has been shown that inflammation is closely correlated
with various stages of cancer development, including initiation,
promotion, malignant conversion, invasion, and metastasis.
The NLR is a biomarker that conveys information about
inflammatory conditions. Thus, it is also useful for patients
with solid cancer in various clinical settings. Ietomi found that
the preoperative NLR can predict the progression of malignant
tumors and proposed that the NLR is correlated with tumor
prognosis (3). Many studies have shown that a high NLR isDOI: 10.6061/clinics/2016(06)04
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correlated with a high recurrence or fatality rate in lung cancer,
gastric cancer, pancreatic cancer, colorectal cancer, hepatocel-
lular carcinoma and breast cancer (4-9).
Thyroid cancer is the most common endocrine tumor. Its
occurrence is associated with local and systemic inflamma-
tory responses. Furthermore, thyroiditis can induce an
immune reaction in the body (10,11). Thus, investigation of
the relationship between the preoperative NLR in papillary
thyroid cancer (PTC) patients and tumor characteristics is
important for understanding tumor growth and the prog-
nosis of thyroid cancer.
’ METHODS
A total of 161 PTC patients, who were diagnosed
according to pathology results after thyroid surgery between
April 2014 and September 2015, were enrolled in this study.
The clinical parameters included age, gender, blood
indices (ANC, ALC, hemoglobin and platelet levels),
thyroid-stimulating hormone (TSH) levels, site of lymph
node metastasis, tumor size and pathological features (e.g.,
multifocality), as well as the American Joint Cancer
Committee (AJCC) tumor-node-metastasis (TNM) stage were
collected. The tumor size was reported as the largest lesion
dimension measured during a histopathological examina-
tion. The preoperative NLR was calculated by dividing the
ANC by the ALC at the thyroid cancer diagnosis. We divided
the cohort into two groups: NLRX2 (high NLR group) and
NLRo2 (low NLR group). The clinicopathological variables,
which were stratified by the NLR were analyzed. Further-
more, a multivariate analysis was conducted to determine
the factors that affect the NLR. Finally, the AJCC TNM stage
of patients who wereX45 years of age was further assessed
using the NLR.
Continuous variables were compared using t-tests for two
groups (when the variance was equal). The Mann Whitney
test was used to compare continuous variables (when the
variance was not equal). The Chi-square test was used to
compare categorical variables. A multivariate analysis
was performed to analyze the factors that affected the
NLR. Spearman’s rank correlation was used to evaluate the
association between the NLR and the AJCC TNM stage. All
reported p-values were two-sided, except for the Pearson
Correlation Coefficient (PCC) and were considered signifi-
cant if p was less than 0.05. The calculations and construction
of graphs were performed with SPSS 20.0 for Windows.
’ RESULTS
The patient characteristics are shown in Table 1. The
median age at presentation was 47 years (range 23-68 years).
The median platelet (PLT) level was 235 109/L (range 41-
417 109/L) and the median hemoglobin level was 131 g/L
(range 79-170 g/L). The median ANC was 3.7 109/L (range
1.8-8.3 109/L), the median ALC was 1.9 109/L (range 0.9-
3.8 109/L) and the median NLR was 2.0 (range 0.64-6.38).
Compared to the low NLR group, patients with PTC in the
high NLR group were more likely to have a larger tumor
(1.30±0.88 cm vs. 0.75±0.46 cm, p=0.000; Table 1 and
Table 2), present with lymph node metastasis (52% vs. 25%,
p=0.000; Table 1) and have multifocality (35% vs. 19%,
p=0.000; Table 1) at diagnosis. No differences were observed
between the two groups regarding age, sex, or PLT,
hemoglobin and TSH levels.
In the multivariate analysis (Table 3), lymph node meta
stasis (r=0.341, p=0.000), tumor size (r=0.271, p=0.000) and
multifocality (r=0.182, p=0.010) were strongly associated
with the NLR. In addition, we determined that the
standard regression coefficients (SRCs) of lymph node
metastasis to the NRL in Model 1 and 2 were 0.341
(p=0.000) and 0.295 (p=0.000), respectively. The SRC of the
tumor size to the NRL in Model 2 was 0.205 (p=0.007).
According to the AJCC TNM staging system, most
patientso45 years were classified as stage I, while patients
with distant metastases were classified as stage II. In
contrast, patients445 years of age with distant metastases
were classified as stage IV (12). Thus, we limited the study
to patients who were X45 years of age and evaluated the
association between the AJCC TNM stage and the NLR.
The number of patients with advanced TNM stage in the
high NLR group was higher than that in the low NLR
group (44% vs. 19%, p=0.013; Table 4). Moreover, Spear-
man’s rank correlation showed that the NLR was strongly
correlated with the AJCC TNM stage, with a rho value of
0.403 (p=0.000; Table 5).
Table 1 - Patient characteristics according to the preoperative neutrophil-to-lymphocyte ratio.
Total NLRX2 NLRo2 p-value
Total 161 (100%) 84 (52%) 77 (48%) -
Age
X45 years 91 (57%) 48 (57%) 43 (56%) 0.708
o45 years 70 (43%) 36 (43%) 34 (44%)
Sex
Female 119 (74%) 62 (74%) 57 (74% ) 0.975
Male 42 (26%) 22 (26%) 20 (26%)
PLT (109/L) 230.91±62.62 231.98±59.36 241.39±60.84 0.326
Hb (g/L) 139.10±31.00 134.39±12.60 132.87±16.17 0.505
TSH level (uIU/ml) 1.95±1.30 1.97±1.14 1.91±1.46 0.779
Tumor size (cm) 1.04±0.76 1.30±0.88 0.75±0.46 0.000
Lymph node metastasis
Yes 63 (39%) 44 (52%) 19 (25%) 0.000
No 98 (61%) 40 (48%) 58 (75%)
Multifocality
Yes 44 (27%) 29 (35%) 15 (19%) 0.035
No 117 (73%) 55 (65%) 62 (81%)
NLR: neutrophil-to-lymphocyte ratio; TSH: thyroid-stimulating hormone; TG: Thyroglobulin.
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’ DISCUSSION
Our study showed that the preoperative NLR was
positively correlated with the size, lymph node metastasis
and multifocality of malignant thyroid tumors. In addition,
this study evaluated the preoperative NLR as a predictive
factor for AJCC TNM stage in PTC patients445 years of age.
A higher preoperative NLR resulted in a larger tumor size
and higher rates of lymph node metastasis and multifocality.
All three of these aspects were correlated with the tumor
burden. Thus, the preoperative NLR directly affected the
TNM staging of thyroid cancer.
These results were also consistent with previous reports of
other tumor types. The NLR has been previously assessed as
an adverse prognostic factor for patients with cancers of the
breast, lung, liver, colon and pancreas. In a meta-analysis
that included over 40,000 patients with a variety of solid
tumors, Templeton et al. showed that the NLR was
associated with unfavorable overall survival (13).
The preoperative NLR might also reflect two interrelated
processes, the systemic inflammatory response and the
condition of the immune system.
An increase in the NLR reflects higher anti-inflammatory
activity in patients with a high ANC and a low ALC.
A correlation between a high NLR and elevated circulating
pro-inflammatory cytokines, including interleukin-17 (IL-17)
(14), interleukin-1 receptor a (IL-1R a), IL-6, IL-7, IL-8, IL-12
and monocyte chemotactic protein-1 (15) was observed.
These inflammatory cytokines may contribute to a tumor
microenvironment that promotes tumor invasion (14,15,16).
In addition, neutrophils can inhibit the secretion of tumor
necrosis factor-a (TNF-a) and generate vascular endothelial
growth factor (VEGF), which has been proposed to play a
pivotal role in tumor development and angiogenesis (17,18).
Tumor progression is induced by inflammatory cells, which
can mediate biological mechanisms, such as angiogenesis,
lymphangiogenesis and the secretion of survival and growth
factors (19). Thus, an increased neutrophil level may exert
adverse effects on the tumor-bearing host, resulting in an
advanced TNM stage.
However, changes in the NLR can result in an immune
system imbalance. The lymphocyte, the main component of
tumor immunity, can induce natural killer lymphocytes and
Table 3 - Multivariate analysis of the preoperative neutrophil-
to-lymphocyte ratio.
PCC/r SRC (95% CI) p-value
(one-sided)
Lymph node metastasis 0.341 0.000
Tumor size 0.271 0.000
Multifocality 0.182 0.010
Model 1
Lymph node metastasis 0.341 (0.323-0.814) 0.000
Model 2
Lymph node metastasis 0.295 (0.245-0.739) 0.000
Tumor size 0.205 (0.061-0.379) 0.007
PCC: Pearson correlation coefficient; SRC: Standard regression coefficient.
Table 2 - Association between tumor size and the preoperative neutrophil-to-lymphocyte ratio.
Table 4 - American Joint Cancer Committee TNM stage and








AJCC TNM Stage (ageX45
years)
Early (I or II) 61 (67) 27 (54) 35 (81) 0.013
Advanced (III or IV) 30 (33) 21 (44) 8 (19)
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stimulate giant cells in tumors to release cytokines, including
interferons and TNF-a, resulting in tumor shrinkage. The
decrease in lymphocyte number might reflect reduced
specific antitumor immune activity (20,21). Furthermore,
tumor-associated macrophages have been associated with a
poor prognosis. M2 macrophages promote cancer cell
growth, as well as suppression of the antitumor immune
response (22).
The NLR may contribute to a tumor growth imbalance and
have a potentially important function in tumor development
and the patient prognosis. The tumor likely exhibits
uncontrolled growth, rapidly proliferates and may even
metastasize into a more suitable microenvironment during
the imbalance.
This study showed that the NLR was positively correlated
with the AJCC TNM stage, which reflects the degree of
malignancy of the tumor. An NLRX2 was present in 52% of
our patients and was associated with increased tumor size
and a high rate of lymph node metastasis and multifocality.
This ratio appears to be a useful and inexpensive predictive
factor for PTC patients. Understandably, the present study
has several limitations, such as its retrospective nature.
Moreover, the optimal cut-off level of the NLR has not yet
been standardized. We used a cut-off level of 2.0, although
this level should be externally validated in independent
cohorts. However, we propose that these results warrant
further investigation in larger studies.
In conclusion, this study demonstrated a positive associa-
tion between a high preoperative NLR and an advanced
AJCC TNM stage in PTC patients 445 years of age. Taken
together, these results indicate the importance of the NLR in
assessing thyroid carcinoma and determining the corre-
sponding treatment choice. This study provides a basis for
enhancement of the lymphocyte value to decrease the NLR
and control tumor growth through immune reactions.
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